tiprankstipranks
Trending News
More News >
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL

Compare Autolus Therapeutics (AUTL) vs. Competitors

Compare
876 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Autolus Therapeutics
$1.44
$377.92M
-1.71
-38.20%
5 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$4.63
$43.44M
-0.46
-66.29%
2 Buy
3 Hold
0 Sell
Moderate Buy
Larimar Therapeutics
$3.41
$291.86M
-1.69
-4.12%
4 Buy
0 Hold
0 Sell
Strong Buy
Benitec Biopharma
$12.13
$410.75M
-11.65
8.63%
3 Buy
0 Hold
0 Sell
Strong Buy
Diamedica Therapeutics
$8.60
$447.87M
-11.91
58.74%
5 Buy
0 Hold
0 Sell
Strong Buy
Contineum Therapeutics, Inc. Class A
$11.76
$429.59M
-5.25
-7.91%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AUTL
Autolus Therapeutics
1.44
-0.78
-35.14%
TVRD
Tvardi Therapeutics
4.51
-9.29
-67.32%
LRMR
Larimar Therapeutics
3.26
<0.01
0.31%
BNTC
Benitec Biopharma
11.71
0.65
5.88%
DMAC
Diamedica Therapeutics
8.54
2.87
50.62%
CTNM
Contineum Therapeutics, Inc. Class A
11.76
-0.72
-5.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts